Title: Pharmacological profile of phosphatidylinositol 3-kinases and related phosphatidylinositols mediating endothelin(A) receptor-operated native TRPC channels in rabbit coronary artery myocytes.
Journal: British journal of pharmacology 20120801
Title: A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiation.
Journal: Nature chemical biology 20120429
Title: Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
Journal: Cancer research 20120201
Title: Phosphoinositide-3-kinase/akt - dependent signaling is required for maintenance of [Ca(2+)](i), I(Ca), and Ca(2+) transients in HL-1 cardiomyocytes.
Journal: Journal of biomedical science 20120101
Title: A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance.
Journal: Molecular cancer research : MCR 20110701
Title: Key role of phosphoinositide 3-kinase class IB in pancreatic cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20101015
Title: Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.
Journal: Journal of medicinal chemistry 20060629
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
Title: Pomel V, et al. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J Med Chem. 2006 Jun 29;49(13):3857-71.
